IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0256291.html
   My bibliography  Save this article

Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe

Author

Listed:
  • Innocent Chingombe
  • Munyaradzi P Mapingure
  • Shirish Balachandra
  • Tendayi N Chipango
  • Fiona Gambanga
  • Angela Mushavi
  • Tsitsi Apollo
  • Chutima Suraratdecha
  • John H Rogers
  • Leala Ruangtragool
  • Elizabeth Gonese
  • Godfrey N Musuka
  • Owen M Mugurungi
  • Tiffany G Harris

Abstract

Zimbabwe has made large strides in addressing HIV. To ensure a continued robust response, a clear understanding of costs associated with its HIV program is critical. We conducted a cross-sectional evaluation in 2017 to estimate the annual average patient cost for accessing Prevention of Mother-To-Child Transmission (PMTCT) services (through antenatal care) and Antiretroviral Treatment (ART) services in Zimbabwe. Twenty sites representing different types of public health facilities in Zimbabwe were included. Data on patient costs were collected through in-person interviews with 414 ART and 424 PMTCT adult patients and through telephone interviews with 38 ART and 47 PMTCT adult patients who had missed their last appointment. The mean and median annual patient costs were examined overall and by service type for all participants and for those who paid any cost. Potential patient costs related to time lost were calculated by multiplying the total time to access services (travel time, waiting time, and clinic visit duration) by potential earnings (US$75 per month assuming 8 hours per day and 5 days per week). Mean annual patient costs for accessing services for the participants was US$20.00 [standard deviation (SD) = US$80.42, median = US$6.00, range = US$0.00–US$12,18.00] for PMTCT and US$18.73 (SD = US$58.54, median = US$8.00, range = US$0.00–US$ 908.00) for ART patients. The mean annual direct medical costs for PMTCT and ART were US$9.78 (SD = US$78.58, median = US$0.00, range = US$0.00–US$ 90) and US$7.49 (SD = US$60.00, median = US$0.00) while mean annual direct non-medical cost for US$10.23 (SD = US$17.35, median = US$4.00) and US$11.23 (SD = US$25.22, median = US$6.00, range = US$0.00–US$ 360.00). The PMTCT and ART costs per visit based on time lost were US$3.53 (US$1.13 to US$8.69) and US$3.43 (US$1.14 to US$8.53), respectively. The mean annual patient costs per person for PMTCT and ART in this evaluation will impact household income since PMTCT and ART services in Zimbabwe are supposed to be free.

Suggested Citation

  • Innocent Chingombe & Munyaradzi P Mapingure & Shirish Balachandra & Tendayi N Chipango & Fiona Gambanga & Angela Mushavi & Tsitsi Apollo & Chutima Suraratdecha & John H Rogers & Leala Ruangtragool & E, 2021. "Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe," PLOS ONE, Public Library of Science, vol. 16(8), pages 1-11, August.
  • Handle: RePEc:plo:pone00:0256291
    DOI: 10.1371/journal.pone.0256291
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256291
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0256291&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0256291?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Foster, Nicola & Vassall, Anna & Cleary, Susan & Cunnama, Lucy & Churchyard, Gavin & Sinanovic, Edina, 2015. "The economic burden of TB diagnosis and treatment in South Africa," Social Science & Medicine, Elsevier, vol. 130(C), pages 42-50.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jhiedon L Florentino & Rosa Mia L Arao & Anna Marie Celina Garfin & Donna Mae G Gaviola & Carlos R Tan & Rajendra Prasad Yadav & Tom Hiatt & Fukushi Morishita & Andrew Siroka & Takuya Yamanaka & Nobuy, 2022. "Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-19, February.
    2. Swati Jha & Nazir Ismail & David Clark & James J Lewis & Shaheed Omar & Andries Dreyer & Violet Chihota & Gavin Churchyard & David W Dowdy, 2016. "Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-11, June.
    3. Karun Sandeep Veesa & Kamalabhai Russell John & Patrick K Moonan & Saravanakumar Puthupalayam Kaliappan & Krishna Manjunath & Karuna D Sagili & Chinnappareddy Ravichandra & Pradeep Aravindan Menon & C, 2018. "Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment – Tamil Nadu, India," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-14, February.
    4. Nicola Foster & Lucy Cunnama & Kerrigan McCarthy & Lebogang Ramma & Mariana Siapka & Edina Sinanovic & Gavin Churchyard & Katherine Fielding & Alison D Grant & Susan Cleary, 2021. "Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 16(5), pages 1-21, May.
    5. Gwenan M Knight & Gabriela B Gomez & Peter J Dodd & David Dowdy & Alice Zwerling & William A Wells & Frank Cobelens & Anna Vassall & Richard G White, 2015. "The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-13, December.
    6. Sedona Sweeney & Anna Vassall & Lorna Guinness & Mariana Siapka & Natsayi Chimbindi & Don Mudzengi & Gabriela B. Gomez, 2020. "Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa," PharmacoEconomics, Springer, vol. 38(6), pages 619-631, June.
    7. Phonenaly Chittamany & Takuya Yamanaka & Sakhone Suthepmany & Thepphouthone Sorsavanh & Phitsada Siphanthong & Jacques Sebert & Kerri Viney & Thipphasone Vixaysouk & Moeko Nagai & Vilath Seevisay & Ki, 2020. "First national tuberculosis patient cost survey in Lao People’s Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV s," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-21, November.
    8. Natasha Pillai & Nicola Foster & Yasmeen Hanifa & Nontobeko Ndlovu & Katherine Fielding & Gavin Churchyard & Violet Chihota & Alison D Grant & Anna Vassall, 2019. "Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-14, February.
    9. Sedona Sweeney & Anna Vassall & Nicola Foster & Victoria Simms & Patrick Ilboudo & Godfather Kimaro & Don Mudzengi & Lorna Guinness, 2016. "Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low‐income and Middle‐income Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 42-52, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0256291. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.